» Articles » PMID: 38179216

Stem Cells and Pain

Abstract

Pain can be defined as an unpleasant sensory and emotional experience caused by either actual or potential tissue damage or even resemble that unpleasant experience. For years, science has sought to find treatment alternatives, with minimal side effects, to relieve pain. However, the currently available pharmacological options on the market show significant adverse events. Therefore, the search for a safer and highly efficient analgesic treatment has become a priority. Stem cells (SCs) are non-specialized cells with a high capacity for replication, self-renewal, and a wide range of differentiation possibilities. In this review, we provide evidence that the immune and neuromodulatory properties of SCs can be a valuable tool in the search for ideal treatment strategies for different types of pain. With the advantage of multiple administration routes and dosages, therapies based on SCs for pain relief have demonstrated meaningful results with few downsides. Nonetheless, there are still more questions than answers when it comes to the mechanisms and pathways of pain targeted by SCs. Thus, this is an evolving field that merits further investigation towards the development of SC-based analgesic therapies, and this review will approach all of these aspects.

Citing Articles

Effects of Combined Intrathecal Mesenchymal Stem Cells and Schwann Cells Transplantation on Neuropathic Pain in Complete Spinal Cord Injury: A Phase II Randomized Active-Controlled Trial.

Akhlaghpasand M, Tavanaei R, Hosseinpoor M, Heidari R, Mohammadi I, Chamanara M Cell Transplant. 2025; 34:9636897241298128.

PMID: 39874104 PMC: 11775971. DOI: 10.1177/09636897241298128.


A Narrative Review of the Dorsal Root Ganglia and Spinal Cord Mechanisms of Action of Neuromodulation Therapies in Neuropathic Pain.

da Silva M, Martelossi-Cebinelli G, Yaekashi K, Carvalho T, Borghi S, Casagrande R Brain Sci. 2024; 14(6).

PMID: 38928589 PMC: 11202229. DOI: 10.3390/brainsci14060589.

References
1.
Rossant J . Stem cells from the Mammalian blastocyst. Stem Cells. 2001; 19(6):477-82. DOI: 10.1634/stemcells.19-6-477. View

2.
Xu Q, Yaksh T . A brief comparison of the pathophysiology of inflammatory versus neuropathic pain. Curr Opin Anaesthesiol. 2011; 24(4):400-7. PMC: 3290396. DOI: 10.1097/ACO.0b013e32834871df. View

3.
Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts A . Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2(2):141-50. DOI: 10.1016/j.stem.2007.11.014. View

4.
Sleem A, Saleh F . Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy. Curr Res Transl Med. 2020; 68(3):105-110. PMC: 7252154. DOI: 10.1016/j.retram.2020.04.003. View

5.
Maxwell S, Bateman D . Choice of opioid analgesics in postoperative care. Lancet. 2007; 369(9578):2000. DOI: 10.1016/S0140-6736(07)60939-8. View